In the US, Trimethadione (trimethadione systemic) is a member of the drug class oxazolidinedione anticonvulsants and is used to treat Epilepsy, Seizure Prevention and Seizures.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N03AC02
CAS registry number (Chemical Abstracts Service)
0000127-48-0
Chemical Formula
C6-H9-N-O3
Molecular Weight
143
Therapeutic Category
Antiepileptic agent
Chemical Name
2,4-Oxazolidinedione, 3,5,5-trimethyl-
Foreign Names
- Trimethadionum (Latin)
- Trimethadion (German)
- Triméthadione (French)
- Trimetadiona (Spanish)
Generic Names
- Trimethadione (OS: BAN, JAN)
- Triméthadione (OS: DCF)
- Troxidone (OS: BAN)
- Trimethinum (IS)
- Trimethadion (PH: Ph. Eur. 6)
- Trimethadione (PH: BP 2010, JP XIV, Ph. Int. 4, USP 23, Ph. Eur. 6)
- Trimethadionum (PH: Ph. Int. 4, Ph. Eur. 6)
Brand Names
- Mino Aleviatin
Dainippon Sumitomo, Japan
- Tridione
Abbott, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and
International Nonproprietary Names.